Acetylsalicylic acid-induced hemolysis and its mechanism
AUTOR(ES)
Shahidi, N. T.
RESUMO
Acetylsalicylic acid (ASA) is known to cause severe hemolytic anemia in some glucose-6-phosphate-dehydrogenase-deficient (G-6-PD-deficient) individuals. To study its mechanism, erythrocytes from an ASA-sensitive patient were transfused into a normal compatible recipient. The administration of 2,5-dihydroxybenzoic (gentisic) acid, a known ASA metabolite with redox properties, to the recipient resulted in a marked decrease in the survival of the patient's erythrocytes. Similar studies with red cells from individuals with A- and Mediterranean variants of G-6-PD revealed no alteration in the erythrocytes' survival. Further studies disclosed that both salicylate and gentisate competitively inhibited the G-6-PD from the ASA-sensitive patient resulting in a marked change in the Km for NADP. These drugs also inhibited the A- and Mediterranean variants of G-6-PD. The magnitude of inhibition, however, was comparatively small and not different from that observed with a normal enzyme.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=322605Documentos Relacionados
- Mechanism of free fatty acid-induced insulin resistance in humans.
- Mechanism of Linolenic Acid-induced Inhibition of Photosynthetic Electron Transport 12
- The Mechanism of Abscisic Acid-induced Proline Accumulation in Barley Leaves
- Acid-induced folding of proteins.
- RIBONUCLEIC ACID-INDUCED CHANGES IN MAMMALIAN CELLS*